Can Rivaroxaban and Edoxaban Be Used During Breastfeeding? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jignesh Patel, adding:
“Can edoxaban and rivaroxaban be prescribed for breastfeeding mothers? The New Horizons clinical trial
Postnatal VTE risk is high, yet many women find injectable low-molecular-weight heparin hard to tolerate.
This phase IV trial measured how two oral anticoagulants pass into breast milk.
Rivaroxaban transferred at low levels (milk:plasma ratio 0.2), while edoxaban mirrored maternal plasma (ratio 0.9).
Modeling predicted low infant exposure for both, with the evidence favoring rivaroxaban as breastfeeding-compatible.”
Title: Can edoxaban and rivaroxaban be prescribed for breastfeeding mothers? The New Horizons clinical trial
Authors: Jignesh Patel, Andrew J. Butler, Giula Mackina, Sinead Duffy, Juliet Scarlett, Jane Alcazar, Loreena Bacarro, Obianuju Nzelu, Hua Xu, Nina Ince, Lewis Couchman, Evangelia Vlachodimitropoulou, Roopen Arya
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference
-
Oct 19, 2026, 10:27Heather M. Johnson: Join the Discussion on Optimizing the CTEPH Diagnostic Pathway
-
Oct 19, 2026, 10:18Flora Peyvandi: Unravelling the Complexity of VWF Through Genetics